Dr. Ethan Alexander Burns, MD

Dr. Burns practices at Houston Methodist Hospital in Houston, Texas, part of Houston Methodist.

Dr. Burns' NPI, 1962933705, was assigned on March 23, 2017. Dr. Burns graduated from Trinity School of Medicine in 2017. Dr. Burns' Texas license number on file is T9065.

Dr. Burns' primary practice is Houston Methodist Hospital, at 6565 Fannin, Houston, TX 77030 in Harris County. The practice phone is (713) 790-2221.

Dr. Burns' primary practice is Houston Methodist Hospital in Houston, Texas, part of Houston Methodist. Dr. Burns is also affiliated with Houston Methodist West Hospital. The medical group on file is Houston Methodist Specialty Physician Group. Dmand AI also links Dr. Burns to 3 more hospitals, 2 group practices and clinics, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Burns practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Burns' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Burns is board certified in hematology by the American Board of Internal Medicine. Dr. Burns has a license on file in Texas.

Dmand AI lists chronic anemia and lung cancer among the conditions Dr. Burns treats.

CMS data shows 926 Medicare services from Dr. Burns across 13 procedure codes in 2024, for 267 Medicare patients. Medicare paid $83,400 for them.

CMS counts 267 Medicare patients who saw Dr. Burns in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Burns' median patient age at 73, with 54% women.

In 2024, Dr. Burns wrote 752 Medicare Part D claims for 118 patients. 81% of them were for generic drugs. CMS names the drug for 539 of them, across 23 drugs with 11 or more claims each, at $250,303 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

Dr. Burns accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Burns as offering telehealth.

Dmand AI links 43 papers to Dr. Burns, published from 2018 to 2024. 2019 was the busiest year, with 12. The most frequent topics are B7-H1 Antigen, Burkitt Lymphoma and Immune Checkpoint Inhibitors. Dr. Burns has published most often in Ann Hematol. Dr. Burns' most frequent co-authors are Maen Abdelrahim, MD, Saro Kasparian, MD and Sai Ravi Kiran R. Pingali, MD.

CMS Open Payments shows 71 general payments to Dr. Burns from 29 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 71% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $238.

Dr. Burns graduated from Trinity School of Medicine in 2017.

Dr. Burns is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.